The client was evaluating launching its antipsychotic drug in India. They requested UC to assist them in understanding the market for their antipsychotic drug in India.
UC developed treatment protocols adopted by Indian psychiatrists with an emphasis on chronic schizophrenia patients. UC studied the price sensitivity of Indian patients to antipsychotic treatments and the perception of Indian physicians of the quality of the antipsychotic drug under study and price sensitivity as per the treatment protocols adopted in India.
The client obtained a patient flow analysis and current treatment paradigm from UC. The client gained feedback on the drug (understudy) from key opinion leaders in key cities in India, and a pricing strategy based on price sensitivity among Indian patients and physicians.